Opioid overdose fatalities; dissolving Overdose Fatality Review Board; providing for Attorney General oversight. Effective date. Emergency.

Changed the document header from 'COMMITTEE SUBSTITUTE' to 'HOUSE OF REPRESENTATIVES - FLOOR VERSION' and updated page numbering and formatting to reflect the bill's progression to the House floor for final consideration.

Adjusted the bill title section to indicate 'ENGROSSED SENATE BILL NO. 391' with updated sponsor attribution formatting.

Reformatted the section headers and indentation throughout the document to match floor version standards, while preserving all substantive legislative text.

Added line numbers and page references throughout the document to track changes during committee review

Adjusted formatting of the bill header to include committee substitute designation

Reformatted section headers and text alignment for readability in the committee version

Meeting transparency rules were updated to allow some organizational and business meetings to be open to the public under the Open Meeting Act, while individual case reviews remain confidential executive sessions.

New language was added stating that documents and writings created during individual case reviews are privileged and cannot be used as evidence in legal proceedings.

Minor formatting and numbering changes were made throughout the bill to align with enrolled legislative standards, including renumbering of subsections and cleanup of page headers.

Transferred the Opioid Overdose Fatality Review Board's duties and authority from the Department of Mental Health and Substance Abuse Services to the Office of the Attorney General.

Added new requirement for the Attorney General to report to the Governor, Senate President Pro Tempore, and House Speaker on overdose trends and systemic issues.

Expanded the Attorney General's authority to request additional information including clinical summaries from treating physicians, chronologies of contact, and second-opinion autopsies.

Repealed the previous provision establishing the Opioid Overdose Fatality Review Board membership requirements.

Extended the Opioid Overdose Fatality Review Board's sunset date from July 1, 2025 to July 1, 2026.

Modified confidentiality provisions to apply to the Attorney General and its employees or contractors instead of the Board and its members.